NCT02568605View on ClinicalTrials.gov

Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2022

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Prebiotic fibre

Oligofructose-enriched inulin (Synergy1)

DIETARY_SUPPLEMENT

Placebo

Maltodextrin

BEHAVIORAL

Weight Loss

All participants will receive 10 one-on-one sessions with a Registered Dietitian designed to achieve 10% weight loss over 6 months. The sessions will focus on nutrition education and behavior counseling to reduce food intake and improve dietary quality.

Trial Locations (1)

T2N 1N4

University of Calgary, Calgary

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Calgary

OTHER

NCT02568605 - Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter